The Latin America Dental Bone Graft Substitutes Market was valued at $41.97 Million in 2026 and projected to reach to $55.48 Million by 2031, representing a compound annual growth rate of 5.7%. Latin America's dental bone graft substitutes market is experiencing steady growth driven by demographic shifts, rising disposable incomes, and increased investment in dental healthcare infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America's dental bone graft substitutes market is valued at USD 41.97 million in 2026 and is projected to reach USD 55.48 million by 2031, growing at a CAGR of 5.7%.
Increasing prevalence of dental diseases and growing patient preference for advanced restorative dental treatments are driving adoption of bone graft substitutes across Latin America.
Improving dental healthcare infrastructure and increasing accessibility to advanced dental procedures in emerging Latin American markets are creating new growth opportunities.
Rising awareness among dental professionals and patients about synthetic and bioengineered bone graft alternatives is accelerating market penetration in the region.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SINUS LIFT (Application) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.1% from 2026 to 2031 |
| Largest Segment | DENTAL HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 0.72 (2026) |
| Revenue Forecast (Billions) | ~USD 1.01 (2031) |
| Segments Covered | Type, Application, Mechanism, End User |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HOYA CORPORATION | Japan | Public Company | Synthetic Bone Grafts / Alloplast (ceramic fillers, dental),Metallic Implants with integrated grafting use-cases,Other dental biomaterials and adjuncts, |
| NOBEL BIOCARE | Switzerland | Private Company | Xenograft-based grafts (competing with BioOss),Allograft and demineralized grafts (Grafton-adjacent use cases),Synthetic and alloplast grafts (Osteograf-adjacent use cases), |
| OSSTEM IMPLANT CO.,LTD | South Korea | Private Company | Xenograft,Allograft,Synthetic Bone Grafts / Alloplast, |
| DENTSPLY SIRONA INC. | United States | Public Company | Xenograft,Allograft,Synthetic Bone Grafts, |
| ENVISTA | United States | Public Company | Xenograft-linked biomaterials (BioOss-adjacent competitive set),Allograft and demineralized grafts (Grafton-adjacent competitive set),Synthetic bone grafts, |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | United Kingdom | Public Company | Biosurgical haemostats used with grafts,Tissue adhesives and wound closure in dental surgery,Internal fixation and clips for oral/maxillofacial, |
| ZIMVIE INC. | United States | Private Company | Xenograft,Allograft,Synthetic Bone Grafts / Alloplast, |
| HENRY SCHEIN, INC. | United States | Public Company | Xenograft (incl. BioOss distribution),Allograft (incl. Grafton and equivalents),Synthetic Bone Grafts / Alloplast (incl. Osteograf-type products), |
HOYA Corporation is a Japanese public company founded in 1941 that operates with 37,752 employees. The company is a diversified global manufacturer serving multiple industries.
Nobel Biocare is a Swiss private company founded in 1981 with 2,552 employees. The company operates in the medical device and healthcare sectors.
OSSTEM IMPLANT CO.,LTD is a South Korean private company founded in 1997 with 2,817 employees. The company specializes in implant and dental solutions.
DENTSPLY SIRONA INC. is a United States-based public company founded in 2015. The company operates in the dental and healthcare technology industry.
ENVISTA is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental and healthcare solutions sector.
Advanced Medical Solutions Group PLC is a United Kingdom-based public company founded in 1991 with 1,800 employees. The company specializes in advanced medical and surgical solutions.
ZIMVIE INC. is a United States-based private company founded in 2021 with 1,770 employees. The company operates in the medical device and healthcare sector.
Henry Schein, Inc. is a United States-based public company founded in 1932 with 25,000 employees. The company is a global distributor of healthcare products and services.
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 8.89 Million |
| Mexico | USD 3.42 Million |
| Argentina | USD 0.71 Million |
| Rest of Latin America | USD 3.86 Million |
The Latin America dental bone graft substitutes market is valued at USD 41.97 million in 2026 and is expected to grow to USD 55.48 million by 2031.
Latin America's dental bone graft substitutes market is projected to grow at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2031.
Latin America's market growth is driven by increasing demand for restorative dental procedures, rising awareness of advanced bone graft alternatives, improving healthcare infrastructure, and growing adoption of dental implantology.
In Latin America, synthetic bone substitutes and allografts are gaining popularity due to their cost-effectiveness, biocompatibility, and proven clinical efficacy in periodontal and implant-supported applications.
Latin America's 5.7% CAGR reflects steady regional growth, slightly below the global 7.1% CAGR, indicating a maturing but expanding market with strong potential as healthcare access improves across the region.
This study involved four major activities to estimate the current size of the dental bone graft substitutes market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The secondary research process involved the extensive use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the dental bone graft substitutes market. It was also used to obtain important information on key players, market classification and segmentation aligned with industry trends down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the dental bone graft substitutes market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends and market dynamics.

Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated using revenue mappings of major product manufacturers and OEMs active in the global dental bone graft substitutes market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global dental bone graft substitutes market was split into various segments and subsegments based on the:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After determining the overall size of the global dental bone graft substitutes market using the above-mentioned methodology, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
A dental bone graft substitute is a biocompatible material used by dentists to rebuild or augment jawbone tissue lost due to various reasons. These substitutes act as a scaffold or supportive structure to promote the growth of new bone tissue in the jaw. They essentially fill the defect or gap where bone loss has occurred.
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
COMPETITIVE LANDSCAPE ASSESSMENT
Full forecast, segment splits, and company analysis for all Dental Bone Graft Substitutes Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report